These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

435 related articles for article (PubMed ID: 31872386)

  • 1. Impact of BRCA1 and BRCA2 mutations on ovarian reserve and fertility preservation outcomes in young women with breast cancer.
    Porcu E; Cillo GM; Cipriani L; Sacilotto F; Notarangelo L; Damiano G; Dirodi M; Roncarati I
    J Assist Reprod Genet; 2020 Mar; 37(3):709-715. PubMed ID: 31872386
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BRCA1/2 gene mutations do not affect the capacity of oocytes from breast cancer candidates for fertility preservation to mature in vitro.
    Grynberg M; Dagher Hayeck B; Papanikolaou EG; Sifer C; Sermondade N; Sonigo C
    Hum Reprod; 2019 Feb; 34(2):374-379. PubMed ID: 30561604
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BRCA carriers have similar reproductive potential at baseline to noncarriers: comparisons in cancer and cancer-free cohorts undergoing fertility preservation.
    Gunnala V; Fields J; Irani M; D'Angelo D; Xu K; Schattman G; Rosenwaks Z
    Fertil Steril; 2019 Feb; 111(2):363-371. PubMed ID: 30527950
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BRCA1 mutation carriers have a lower number of mature oocytes after ovarian stimulation for IVF/PGD.
    Derks-Smeets IAP; van Tilborg TC; van Montfoort A; Smits L; Torrance HL; Meijer-Hoogeveen M; Broekmans F; Dreesen JCFM; Paulussen ADC; Tjan-Heijnen VCG; Homminga I; van den Berg MMJ; Ausems MGEM; de Rycke M; de Die-Smulders CEM; Verpoest W; van Golde R
    J Assist Reprod Genet; 2017 Nov; 34(11):1475-1482. PubMed ID: 28831696
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased chemotherapy-induced ovarian reserve loss in women with germline BRCA mutations due to oocyte deoxyribonucleic acid double strand break repair deficiency.
    Oktay KH; Bedoschi G; Goldfarb SB; Taylan E; Titus S; Palomaki GE; Cigler T; Robson M; Dickler MN
    Fertil Steril; 2020 Jun; 113(6):1251-1260.e1. PubMed ID: 32331767
    [TBL] [Abstract][Full Text] [Related]  

  • 6. COH outcomes in breast cancer patients for fertility preservation: a comparison with the expected response by age.
    Malacarne E; Devesa M; Martinez F; Rodriguez I; Coroleu B
    J Assist Reprod Genet; 2020 Dec; 37(12):3069-3076. PubMed ID: 32945994
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of BRCA mutations and hormone receptor status on reproductive potential in breast cancer patients undergoing fertility preservation.
    Kim SW; Kim TH; Han JY; Kim SK; Lee JR; Jee UC; Suh CS; Kim SH
    Gynecol Endocrinol; 2022 Mar; 38(3):227-230. PubMed ID: 34775902
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Should a systematic fertility preservation be proposed to healthy women carrying a BRCA1/2 mutation?].
    Sénéchal C; Rousset-Jablonski C
    Gynecol Obstet Fertil; 2015 Dec; 43(12):800-5. PubMed ID: 26476890
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fertility preservation for genetic diseases leading to premature ovarian insufficiency (POI).
    La Marca A; Mastellari E
    J Assist Reprod Genet; 2021 Apr; 38(4):759-777. PubMed ID: 33495935
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BRCA-related ATM-mediated DNA double-strand break repair and ovarian aging.
    Turan V; Oktay K
    Hum Reprod Update; 2020 Jan; 26(1):43-57. PubMed ID: 31822904
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Navigating the body of literature assessing BRCA1/2 mutations and markers of ovarian function: a systematic review and meta-analysis.
    Cordeiro Mitchell CN; McGuinness B; Fine E; Kearns WG; Christianson MS; Segars J; Pastore LM
    J Assist Reprod Genet; 2020 May; 37(5):1037-1055. PubMed ID: 32212026
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reproductive potential and performance of fertility preservation strategies in BRCA-mutated breast cancer patients.
    Lambertini M; Goldrat O; Ferreira AR; Dechene J; Azim HA; Desir J; Delbaere A; t'Kint de Roodenbeke MD; de Azambuja E; Ignatiadis M; Demeestere I
    Ann Oncol; 2018 Jan; 29(1):237-243. PubMed ID: 29045555
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of BRCA1 Mutations with Impaired Ovarian Reserve: Connection Between Infertility and Breast/Ovarian Cancer Risk.
    Giordano S; Garrett-Mayer E; Mittal N; Smith K; Shulman L; Passaglia C; Gradishar W; Pavone ME
    J Adolesc Young Adult Oncol; 2016 Dec; 5(4):337-343. PubMed ID: 27513691
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ovarian Stimulation in Patients With Cancer: Impact of Letrozole and BRCA Mutations on Fertility Preservation Cycle Outcomes.
    Turan V; Bedoschi G; Emirdar V; Moy F; Oktay K
    Reprod Sci; 2018 Jan; 25(1):26-32. PubMed ID: 28874104
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of cancer stage and grade on fertility preservation outcome and ovarian stimulation response.
    Volodarsky-Perel A; Cohen Y; Arab S; Son WY; Suarthana E; Dahan MH; Tulandi T; Buckett W
    Hum Reprod; 2019 Mar; 34(3):530-538. PubMed ID: 30689898
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of ovarian reserve and reproductive outcomes in
    Ponce J; Fernandez-Gonzalez S; Calvo I; Climent M; Peñafiel J; Feliubadaló L; Teulé A; Lázaro C; Brunet JM; Candás-Estébanez B; Durán Retamal M
    Int J Gynecol Cancer; 2020 Jan; 30(1):83-88. PubMed ID: 31780568
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fertility preservation in women harboring deleterious BRCA mutations: ready for prime time?
    Peccatori FA; Mangili G; Bergamini A; Filippi F; Martinelli F; Ferrari F; Noli S; Rabaiotti E; Candiani M; Somigliana E
    Hum Reprod; 2018 Feb; 33(2):181-187. PubMed ID: 29207007
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-Müllerian hormone serum concentrations of women with germline BRCA1 or BRCA2 mutations.
    Phillips KA; Collins IM; Milne RL; McLachlan SA; Friedlander M; Hickey M; Stern C; Hopper JL; Fisher R; Kannemeyer G; Picken S; Smith CD; Kelsey TW; Anderson RA;
    Hum Reprod; 2016 May; 31(5):1126-32. PubMed ID: 27094481
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Response to ovarian stimulation is not impacted by a breast cancer diagnosis.
    Quinn MM; Cakmak H; Letourneau JM; Cedars MI; Rosen MP
    Hum Reprod; 2017 Mar; 32(3):568-574. PubMed ID: 28122888
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BRCA1 germline mutations may be associated with reduced ovarian reserve.
    Wang ET; Pisarska MD; Bresee C; Chen YD; Lester J; Afshar Y; Alexander C; Karlan BY
    Fertil Steril; 2014 Dec; 102(6):1723-8. PubMed ID: 25256924
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.